Matt O'Brien

Matt O'Brien is a senior research analyst and managing director at Piper Sandler covering medical technology and devices. Before joining Piper Sandler in 2014, O'Brien covered medical technology at William Blair for 10 years. Additional work experience includes five years of middle-market investment banking financial advisory work and two years at a healthcare manufacturing and distribution company. O'Brien holds an MBA from the University of Chicago Booth School of Management and a Bachelor of Science from DePaul University in finance.

Universe Coverage

Medical Technology and Devices
ATEC	Alphatec Holdings, Inc.
ATRC	AtriCure, Inc.
BBNX	Beta Bionics, Inc.
BSX	Boston Scientific Corporation
CARL	Carlsmed, Inc.
CNMD	CONMED Corporation
CVRX	CVRx, Inc.
DXCM	DexCom, Inc.
GMED	Globus Medical, Inc.
HTFL	HeartFlow, Inc.
PODD	Insulet Corporation
ITGR	Integer Holdings Corp.
KMTS	Kestra Medical Technologies Ltd.
MDT	Medtronic plc
OBIO	Orchestra Biomed Holdings, Inc.
KIDS	OrthoPediatrics Corp.
PEN	Penumbra, Inc.
PRCT	PROCEPT BioRobotics Corp.
SI	Shoulder Innovations, Inc.
SIBN	SI-BONE, Inc.
SYK	Stryker Corporation
TNDM	Tandem Diabetes Care, Inc.
TELA	TELA Bio, Inc.
TFX	Teleflex Incorporated
TMDX	TransMedics Group, Inc.
ZBH	Zimmer Biomet Holdings, Inc.